Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.1.1.3 (
HSD
)
3,464
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The in vitro inhibitory effects of 23 compounds designated as possible endocrine-disrupting chemicals, such as alkylphenols, phthalate esters, phytoestrogens, organotins, and pesticides, on the enzyme activity of the isozymes of human 11beta-
HSD
, type 1 and 2, were examined. Human liver microsomal 11beta-
HSD
type 1 was inhibited by 4-nonylphenol (4-NP) and diethylhexyl
adipate
(IC50 = 49.3 and 49.4 mM, respectively). Further, human kidney microsomal 11beta-
HSD
type 2 was inhibited by triphenyltin, tributyltin, 4-t-octylphenol, 4-NP, 4-n-octylphenol, 4-n-nonylphenol, and dicyclohexyl phthalate (IC50 = 3.3, 16.5, 8.9, 20.3, 23.5, 26.2 and 46.5 microM, respectively). The other chemicals studied did not significantly inhibit the enzyme at concentrations lower than 50 microM. The expression of mRNA of the isozymes in gonads, accessory genital glands, and adrenal glands were investigated by RT-PCR. 11beta-
HSD
type 1 was detected in human testis, ovary, and prostate. The level in the adrenal gland(s) was similar to that in the liver, which is known to be expressed in large quantities. In contrast, except for the prostate, only small amounts of the 11beta-
HSD
type 2 isozyme were detected in these human tissues compared to kidney.
...
PMID:Inhibitory effects of some possible endocrine-disrupting chemicals on the isozymes of human 11beta-hydroxysteroid dehydrogenase and expression of their mRNA in gonads and adrenal glands. 1618 81